EP
COLL icon

Eversept Partners’s Collegium Pharmaceutical COLL Stock Holding History

Eversept Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-111,361
Closed -$2.29M – 65
2019
Q4 		$2.29M Sell
111,361
-48,934
-31% -$816K 0.4% 44
2019
Q3 		$1.84M Buy
160,295
+19,295
+14% +$220K 0.57% 39
2019
Q2 		$1.85M Buy
+141,000
New +$1.89M 0.52% 37

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Eversept Partners's COLL Position: Q1 2020 in Review

Eversept Partners sold out of Collegium Pharmaceutical (COLL) in Q1 2020, closing a stake of 111,361 shares — an estimated $2.29M sold.

Eversept Partners first reported a position in COLL in Q2 2019 and held it in 3 quarters. The position peaked at $2.29M in Q4 2019. 159 funds tracked by Wall St. Rank hold COLL as of Q1 2020.

  • Eversept Partners reported no remaining Collegium Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Eversept Partners sold 111,361 Collegium Pharmaceutical shares in Q1 2020, an estimated $2.29M.
  • Eversept Partners first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 3 quarters.
  • Eversept Partners's Collegium Pharmaceutical position peaked at $2.29M in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2020.

Based on Eversept Partners's 13F filing for Q1 2020, filed 13 May 2020.